Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 07/2011, Volume 338, Issue 1, pp. 114 - 124
The endogenous cannabinoid (endocannabinoid) anandamide is principally degraded by the integral membrane enzyme fatty acid amide hydrolase (FAAH)....
ALPHA-KETOHETEROCYCLE INHIBITORS | NEUROPATHIC PAIN | ANANDAMIDE HYDROLYSIS | ENZYMES | IN-VIVO | FAAH INHIBITOR | PHARMACOLOGY & PHARMACY | MICE | REVERSIBLE INHIBITORS | COMPLEX PROTEOMES | BLOCKADE | Inflammation - pathology | Humans | Male | Pyridazines - pharmacology | Urea - chemistry | Pain - enzymology | Piperidines - pharmacology | Inflammation - drug therapy | Pain - drug therapy | Enzyme Inhibitors - chemistry | Urea - analogs & derivatives | Pyridazines - therapeutic use | Amidohydrolases - metabolism | Piperidines - chemistry | Mice, Inbred C57BL | Enzyme Inhibitors - pharmacology | Rats | Amidohydrolases - antagonists & inhibitors | Enzyme Inhibitors - therapeutic use | Rats, Sprague-Dawley | Pyridazines - chemistry | Urea - therapeutic use | Animals | Piperidines - therapeutic use | Mice | Inflammation - enzymology | Urea - pharmacology
ALPHA-KETOHETEROCYCLE INHIBITORS | NEUROPATHIC PAIN | ANANDAMIDE HYDROLYSIS | ENZYMES | IN-VIVO | FAAH INHIBITOR | PHARMACOLOGY & PHARMACY | MICE | REVERSIBLE INHIBITORS | COMPLEX PROTEOMES | BLOCKADE | Inflammation - pathology | Humans | Male | Pyridazines - pharmacology | Urea - chemistry | Pain - enzymology | Piperidines - pharmacology | Inflammation - drug therapy | Pain - drug therapy | Enzyme Inhibitors - chemistry | Urea - analogs & derivatives | Pyridazines - therapeutic use | Amidohydrolases - metabolism | Piperidines - chemistry | Mice, Inbred C57BL | Enzyme Inhibitors - pharmacology | Rats | Amidohydrolases - antagonists & inhibitors | Enzyme Inhibitors - therapeutic use | Rats, Sprague-Dawley | Pyridazines - chemistry | Urea - therapeutic use | Animals | Piperidines - therapeutic use | Mice | Inflammation - enzymology | Urea - pharmacology
Journal Article
Gastroenterology, ISSN 0016-5085, 04/2017, Volume 152, Issue 5, pp. S76 - S76
Journal Article
Gastroenterology, ISSN 0016-5085, 2017, Volume 152, Issue 5, pp. S76 - S76
Journal Article
Nature Structural & Molecular Biology, ISSN 1545-9993, 12/2004, Volume 11, Issue 12, pp. 1192 - 1197
MEK1 and MEK2 are closely related, dual-specificity tyrosine/threonine protein kinases found in the Ras/Raf/MEK/ERK mitogen-activated protein kinase (MAPK)...
MECHANISM | RECOGNITION | SPECIFICITY | CRYSTAL-STRUCTURE | TYROSINE KINASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | CASCADE | IDENTIFICATION | CELL BIOLOGY | BIOPHYSICS | PATHWAY | GROWTH | ACTIVATED PROTEIN-KINASES | MAP Kinase Kinase 1 - antagonists & inhibitors | Humans | Enzyme Inhibitors - pharmacology | Models, Molecular | MAP Kinase Kinase 1 - metabolism | MAP Kinase Kinase 2 - metabolism | MAP Kinase Kinase 2 - chemistry | MAP Kinase Kinase 1 - chemistry | MAP Kinase Kinase 2 - antagonists & inhibitors | Enzyme Inhibitors - chemistry | Protein Structure, Quaternary | Conserved Sequence | Molecular Structure | Structural Homology, Protein | Binding Sites | Dimerization | Physiological aspects | Cellular signal transduction | Research | Structure | Protein kinases
MECHANISM | RECOGNITION | SPECIFICITY | CRYSTAL-STRUCTURE | TYROSINE KINASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | CASCADE | IDENTIFICATION | CELL BIOLOGY | BIOPHYSICS | PATHWAY | GROWTH | ACTIVATED PROTEIN-KINASES | MAP Kinase Kinase 1 - antagonists & inhibitors | Humans | Enzyme Inhibitors - pharmacology | Models, Molecular | MAP Kinase Kinase 1 - metabolism | MAP Kinase Kinase 2 - metabolism | MAP Kinase Kinase 2 - chemistry | MAP Kinase Kinase 1 - chemistry | MAP Kinase Kinase 2 - antagonists & inhibitors | Enzyme Inhibitors - chemistry | Protein Structure, Quaternary | Conserved Sequence | Molecular Structure | Structural Homology, Protein | Binding Sites | Dimerization | Physiological aspects | Cellular signal transduction | Research | Structure | Protein kinases
Journal Article
Journal of Immunology, ISSN 0022-1767, 02/2014, Volume 192, Issue 4, pp. 1907 - 1917
The identification of MHC class I ligands for rhesus macaque killer cell Ig-like receptors (KIRs) is fundamental to our basic understanding of KIR and MHC...
MHC CLASS-I | VIRUS-INFECTION | NK CELLS | KIR HAPLOTYPES | HLA-B | DOWN-REGULATION | MAJOR HISTOCOMPATIBILITY COMPLEX | HIV-1 NEF PROTEIN | IMMUNOLOGY | IMMUNOGLOBULIN-LIKE RECEPTOR | RAPID EVOLUTION | Protein Structure, Tertiary | Amino Acid Sequence | Cell Line | Receptors, KIR - genetics | Jurkat Cells | Humans | HLA-B Antigens - immunology | Histocompatibility Antigens Class I - immunology | Macaca mulatta - immunology | Molecular Sequence Data | Protein Binding - immunology | Histocompatibility Antigens Class I - metabolism | Animals | Macaca mulatta - genetics | Killer Cells, Natural - immunology | Ligands | Epitopes, T-Lymphocyte - immunology | Killer Cells, Natural - metabolism | Receptors, KIR - immunology | Epitopes, T-Lymphocyte - metabolism
MHC CLASS-I | VIRUS-INFECTION | NK CELLS | KIR HAPLOTYPES | HLA-B | DOWN-REGULATION | MAJOR HISTOCOMPATIBILITY COMPLEX | HIV-1 NEF PROTEIN | IMMUNOLOGY | IMMUNOGLOBULIN-LIKE RECEPTOR | RAPID EVOLUTION | Protein Structure, Tertiary | Amino Acid Sequence | Cell Line | Receptors, KIR - genetics | Jurkat Cells | Humans | HLA-B Antigens - immunology | Histocompatibility Antigens Class I - immunology | Macaca mulatta - immunology | Molecular Sequence Data | Protein Binding - immunology | Histocompatibility Antigens Class I - metabolism | Animals | Macaca mulatta - genetics | Killer Cells, Natural - immunology | Ligands | Epitopes, T-Lymphocyte - immunology | Killer Cells, Natural - metabolism | Receptors, KIR - immunology | Epitopes, T-Lymphocyte - metabolism
Journal Article
Gastroenterology, ISSN 0016-5085, 2016, Volume 152, Issue 1, pp. 206 - 217.e2
Background & Aims The inflammatory bowel diseases (IBD) ulcerative colitis (UC) and Crohn’s disease (CD) cause significant morbidity and are increasing in...
Gastroenterology and Hepatology | Trans-Ethnic | SNP | Genetic Analysis | Risk Factor | CROHNS-DISEASE | VARIANTS | ULCERATIVE-COLITIS | GENES | RISK | KOREANS | IMMUNOCHIP ANALYSIS | GASTROENTEROLOGY & HEPATOLOGY | Crohn Disease - genetics | Interleukin-12 Subunit p40 - genetics | Sorting Nexins - genetics | Tenascin - genetics | Humans | Colitis, Ulcerative - genetics | Receptors, Virus - genetics | Genotyping Techniques | HLA-DQ alpha-Chains - genetics | Case-Control Studies | Receptors, Chemokine - genetics | Receptors, Prostaglandin E, EP4 Subtype - genetics | European Continental Ancestry Group - genetics | Genetic Predisposition to Disease - genetics | Genome-Wide Association Study | HLA-DRB1 Chains - genetics | African Americans - genetics | Repressor Proteins - genetics | Ubiquitin Thiolesterase - genetics | Receptors, Interleukin - genetics | Cell Adhesion Molecules, Neuronal - genetics | KCNQ2 Potassium Channel - genetics | Polymorphism, Single Nucleotide | Adenylyl Cyclases - genetics | GPI-Linked Proteins - genetics | Receptors, CXCR6 | Medical research | Gastrointestinal diseases | Genomics | African Americans | Genetic research | Medicine, Experimental | Disease susceptibility | genetic analysis | Risk factor
Gastroenterology and Hepatology | Trans-Ethnic | SNP | Genetic Analysis | Risk Factor | CROHNS-DISEASE | VARIANTS | ULCERATIVE-COLITIS | GENES | RISK | KOREANS | IMMUNOCHIP ANALYSIS | GASTROENTEROLOGY & HEPATOLOGY | Crohn Disease - genetics | Interleukin-12 Subunit p40 - genetics | Sorting Nexins - genetics | Tenascin - genetics | Humans | Colitis, Ulcerative - genetics | Receptors, Virus - genetics | Genotyping Techniques | HLA-DQ alpha-Chains - genetics | Case-Control Studies | Receptors, Chemokine - genetics | Receptors, Prostaglandin E, EP4 Subtype - genetics | European Continental Ancestry Group - genetics | Genetic Predisposition to Disease - genetics | Genome-Wide Association Study | HLA-DRB1 Chains - genetics | African Americans - genetics | Repressor Proteins - genetics | Ubiquitin Thiolesterase - genetics | Receptors, Interleukin - genetics | Cell Adhesion Molecules, Neuronal - genetics | KCNQ2 Potassium Channel - genetics | Polymorphism, Single Nucleotide | Adenylyl Cyclases - genetics | GPI-Linked Proteins - genetics | Receptors, CXCR6 | Medical research | Gastrointestinal diseases | Genomics | African Americans | Genetic research | Medicine, Experimental | Disease susceptibility | genetic analysis | Risk factor
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 10/2014, Volume 111, Issue 41, p. 14882
 Efforts to develop unbiased screens for identifying novel function-blocking monoclonal antibodies (mAbs) in human carcinomatous states have been hampered by...
Tissue | Collagen | Monoclonal antibodies | Breast cancer | Tumors
Tissue | Collagen | Monoclonal antibodies | Breast cancer | Tumors
Journal Article
Pharmacology, Biochemistry and Behavior, ISSN 0091-3057, 10/2011, Volume 99, Issue 4, pp. 718 - 725
Fatty acid amide hydrolase (FAAH) is the primary degradative enzyme of the endocannabinoid anandamide ( -arachidonoylethanolamine), which activates cannabinoid...
Fatty acid amide hydrolase (FAAH) | Endocannabinoid | Chronic inflammation | Inflammatory pain | Collagen-induced arthritis | Anandamide | RHEUMATOID-ARTHRITIS | SQUIRREL-MONKEYS | ANANDAMIDE HYDROLYSIS | INHIBITOR URB597 | NEUROSCIENCES | INDUCED PAW EDEMA | NEUROPATHIC PAIN | PRECIPITATED WITHDRAWAL | ACTIVATED-RECEPTOR-ALPHA | BEHAVIORAL SCIENCES | PHARMACOLOGY & PHARMACY | CANNABINOID-INDUCED ANTINOCICEPTION | Arthritis, Experimental - genetics | Amidohydrolases - genetics | Bornanes - pharmacology | Receptor, Cannabinoid, CB2 - drug effects | Amidohydrolases - antagonists & inhibitors | Genotype | Male | Pain Measurement - drug effects | Hot Temperature | Mice, Knockout | Arthritis, Experimental - pathology | Phenotype | Animals | Hyperalgesia - drug therapy | Amidohydrolases - physiology | Arthritis, Experimental - prevention & control | Receptor, Cannabinoid, CB1 - drug effects | Mice, Inbred DBA | Benzamides - pharmacology | Mice | Foot - pathology | Carbamates - pharmacology | Pyrazoles - pharmacology | Enzymes | Rheumatoid factor | Hydrolases | Arthritis | Fatty acids | Analysis | collagen-induced arthritis | endocannabinoid | inflammatory pain | fatty acid amide hydrolase (FAAH) | anandamide | chronic inflammation
Fatty acid amide hydrolase (FAAH) | Endocannabinoid | Chronic inflammation | Inflammatory pain | Collagen-induced arthritis | Anandamide | RHEUMATOID-ARTHRITIS | SQUIRREL-MONKEYS | ANANDAMIDE HYDROLYSIS | INHIBITOR URB597 | NEUROSCIENCES | INDUCED PAW EDEMA | NEUROPATHIC PAIN | PRECIPITATED WITHDRAWAL | ACTIVATED-RECEPTOR-ALPHA | BEHAVIORAL SCIENCES | PHARMACOLOGY & PHARMACY | CANNABINOID-INDUCED ANTINOCICEPTION | Arthritis, Experimental - genetics | Amidohydrolases - genetics | Bornanes - pharmacology | Receptor, Cannabinoid, CB2 - drug effects | Amidohydrolases - antagonists & inhibitors | Genotype | Male | Pain Measurement - drug effects | Hot Temperature | Mice, Knockout | Arthritis, Experimental - pathology | Phenotype | Animals | Hyperalgesia - drug therapy | Amidohydrolases - physiology | Arthritis, Experimental - prevention & control | Receptor, Cannabinoid, CB1 - drug effects | Mice, Inbred DBA | Benzamides - pharmacology | Mice | Foot - pathology | Carbamates - pharmacology | Pyrazoles - pharmacology | Enzymes | Rheumatoid factor | Hydrolases | Arthritis | Fatty acids | Analysis | collagen-induced arthritis | endocannabinoid | inflammatory pain | fatty acid amide hydrolase (FAAH) | anandamide | chronic inflammation
Journal Article
Inflammatory Bowel Diseases, ISSN 1078-0998, 03/2013, Volume 19, Issue 3, pp. 662 - 668
Introduction: Variation in adherence to management guidelines for inflammatory bowel disease (IBD) suggests variable quality of care. Quality indicators (QIs)...
Inflammatory bowel disease | Quality | Quality indicators | Crohn's disease | Quality measures | Quality of care | Ulcerative colitis | SET | MANAGEMENT | CROHNS-DISEASE | ULCERATIVE-COLITIS | GUIDELINES | ADULTS | EXPERTS | quality indicators | quality of care | inflammatory bowel disease | quality | CHILDREN | ARTHRITIS CARE | quality measures | ulcerative colitis | GASTROENTEROLOGY & HEPATOLOGY | OF-CARE | Group Processes | Outcome and Process Assessment (Health Care) | United States | Humans | Patient Safety | Quality Indicators, Health Care | Quality of Life | Inflammatory Bowel Diseases - therapy | Practice Guidelines as Topic
Inflammatory bowel disease | Quality | Quality indicators | Crohn's disease | Quality measures | Quality of care | Ulcerative colitis | SET | MANAGEMENT | CROHNS-DISEASE | ULCERATIVE-COLITIS | GUIDELINES | ADULTS | EXPERTS | quality indicators | quality of care | inflammatory bowel disease | quality | CHILDREN | ARTHRITIS CARE | quality measures | ulcerative colitis | GASTROENTEROLOGY & HEPATOLOGY | OF-CARE | Group Processes | Outcome and Process Assessment (Health Care) | United States | Humans | Patient Safety | Quality Indicators, Health Care | Quality of Life | Inflammatory Bowel Diseases - therapy | Practice Guidelines as Topic
Journal Article
Bioorganic & Medicinal Chemistry Letters, ISSN 0960-894X, 2008, Volume 18, Issue 24, pp. 6501 - 6504
A novel series of benzhydroxamic esters were identified as potent MEK inhibitors. Optimization of these esters produced the two clinical candidates and . A...
MEK | Benzhydroxamate ester | CI-1040 | Mitogen-activated protein kinase | Oncology | PD 0325901 | MAP/ERK kinase | Hydroxamate ester | Anthranilic acid | ERK | CHEMISTRY, MEDICINAL | MAP KINASE | CHEMISTRY, ORGANIC | COLON | CANCER | PATHWAY | PROGRESS | FLUORINE | Neoplasm Transplantation | Chemistry, Pharmaceutical - methods | Diphenylamine - pharmacology | ortho-Aminobenzoates - chemistry | Benzoates - chemistry | Enzyme Inhibitors - pharmacology | Solubility | Hydroxamic Acids - chemistry | Enzyme Inhibitors - chemical synthesis | Benzamides - chemical synthesis | Diphenylamine - analogs & derivatives | Animals | Drug Design | Cell Line, Tumor | Inhibitory Concentration 50 | Benzamides - pharmacology | Mice | MAP Kinase Kinase Kinase 1 - antagonists & inhibitors | Diphenylamine - chemical synthesis | Esters | Mitogens | Index Medicus
MEK | Benzhydroxamate ester | CI-1040 | Mitogen-activated protein kinase | Oncology | PD 0325901 | MAP/ERK kinase | Hydroxamate ester | Anthranilic acid | ERK | CHEMISTRY, MEDICINAL | MAP KINASE | CHEMISTRY, ORGANIC | COLON | CANCER | PATHWAY | PROGRESS | FLUORINE | Neoplasm Transplantation | Chemistry, Pharmaceutical - methods | Diphenylamine - pharmacology | ortho-Aminobenzoates - chemistry | Benzoates - chemistry | Enzyme Inhibitors - pharmacology | Solubility | Hydroxamic Acids - chemistry | Enzyme Inhibitors - chemical synthesis | Benzamides - chemical synthesis | Diphenylamine - analogs & derivatives | Animals | Drug Design | Cell Line, Tumor | Inhibitory Concentration 50 | Benzamides - pharmacology | Mice | MAP Kinase Kinase Kinase 1 - antagonists & inhibitors | Diphenylamine - chemical synthesis | Esters | Mitogens | Index Medicus
Journal Article
ACS Medicinal Chemistry Letters, ISSN 1948-5875, 02/2011, Volume 2, Issue 2, pp. 91 - 96
Fatty acid amide hydrolase (FAAH) is an integral membrane serine hydrolase that degrades the fatty acid amide family of signaling lipids, including the...
endocannabinoid | FAAH | irreversible inhibitor | clinical candidate | ALPHA-KETOHETEROCYCLE INHIBITORS | TARGET | URB597 | CHEMISTRY, MEDICINAL | MECHANISM | ANANDAMIDE | INACTIVATION | ENZYME | ACID AMIDE HYDROLASE | ESTERS | CHEMISTRY
endocannabinoid | FAAH | irreversible inhibitor | clinical candidate | ALPHA-KETOHETEROCYCLE INHIBITORS | TARGET | URB597 | CHEMISTRY, MEDICINAL | MECHANISM | ANANDAMIDE | INACTIVATION | ENZYME | ACID AMIDE HYDROLASE | ESTERS | CHEMISTRY
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 10/2014, Volume 111, Issue 41, pp. 14882 - 14887
Efforts to develop unbiased screens for identifying novel functionblocking monoclonal antibodies (mAbs) in human carcinomatous states have been hampered by the...
Antigens | Cell growth | Carcinoma | Collagens | Cell lines | Bones | Breast cancer | Metastasis | Integrins | Tumors | Extracellular matrix | Mouse model | Bone | MDA-MB-231 | mouse model | ALPHABETA INTEGRIN | INTEGRIN ALPHA-2-BETA-1 | BREAST-CANCER METASTASIS | MULTIDISCIPLINARY SCIENCES | CELL INVASION | bone | I COLLAGEN | SIGNALING PROMOTES | DEFICIENT MOUSE | metastasis | PROSTATE-CANCER | EXTRACELLULAR-MATRIX | extracellular matrix | BASEMENT-MEMBRANE | Cell Proliferation | Breast Neoplasms - immunology | Humans | Bone Neoplasms - secondary | Integrin alpha2 - metabolism | Transcriptome - genetics | Bone Neoplasms - pathology | Xenograft Model Antitumor Assays | Animals | Breast Neoplasms - genetics | Mice, Nude | Chickens | Antigens, Neoplasm - metabolism | Cell Line, Tumor | Immunoassay - methods | Female | Antibodies, Monoclonal - immunology | Extravasation of Diagnostic and Therapeutic Materials | Three-dimensional display systems | Usage | Oncology, Experimental | Monoclonal antibodies | Development and progression | Models | Research | Health aspects | Cancer | Biological Sciences
Antigens | Cell growth | Carcinoma | Collagens | Cell lines | Bones | Breast cancer | Metastasis | Integrins | Tumors | Extracellular matrix | Mouse model | Bone | MDA-MB-231 | mouse model | ALPHABETA INTEGRIN | INTEGRIN ALPHA-2-BETA-1 | BREAST-CANCER METASTASIS | MULTIDISCIPLINARY SCIENCES | CELL INVASION | bone | I COLLAGEN | SIGNALING PROMOTES | DEFICIENT MOUSE | metastasis | PROSTATE-CANCER | EXTRACELLULAR-MATRIX | extracellular matrix | BASEMENT-MEMBRANE | Cell Proliferation | Breast Neoplasms - immunology | Humans | Bone Neoplasms - secondary | Integrin alpha2 - metabolism | Transcriptome - genetics | Bone Neoplasms - pathology | Xenograft Model Antitumor Assays | Animals | Breast Neoplasms - genetics | Mice, Nude | Chickens | Antigens, Neoplasm - metabolism | Cell Line, Tumor | Immunoassay - methods | Female | Antibodies, Monoclonal - immunology | Extravasation of Diagnostic and Therapeutic Materials | Three-dimensional display systems | Usage | Oncology, Experimental | Monoclonal antibodies | Development and progression | Models | Research | Health aspects | Cancer | Biological Sciences
Journal Article
Gastroenterology, ISSN 0016-5085, 6/2017, Volume 152, Issue 8, pp. 2082 - 2083
Journal Article